More direct evidence came from the results with a soluble C18-ceramide analog drug, LCL-461 which accumulated in mitochondria and induced lethal mitophagy in AML cells expressing FLT3 mutations and in blasts obtained from FLT3-ITD1 AML patients [249]. The gene discussed is FLT3; the disease is acute myeloid leukemia.